This week, I will take a closer look at a new approach in cancer immunotherapy from a tiny biotech company — OncoSec Medical . Before I get started, a word or two of caution: OncoSec is a micro-cap biotech company with a single-digit stock price and an enterprise value of just $2.7 million.